Neuropeptide research discloses part of the secrets of Alzheimer's disease neuropathogenesis: State of the art 2004

Neuroscience Letters

Volumn 361, Issue 1-3, 2004, Pages 124-127

  Van Leeuwen, F W ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

Molecular misreading; Synucleinopathies; Tauopathies; Ubiquitin; Vasopressin

Indexed keywords

DINUCLEOTIDE; NEUROPEPTIDE; RNA POLYMERASE; UBIQUITIN;

ALZHEIMER DISEASE; GENE DELETION; GENETIC TRANSCRIPTION; HUMAN; MOLECULAR DYNAMICS; NEUROPATHOLOGY; NONHUMAN; OPEN READING FRAME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEPLETION; QUALITY CONTROL; RIBOSOMAL FRAMESHIFTING; SEQUENCE ANALYSIS; SHORT SURVEY;

EID: 2342501833     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.12.050     Document Type: Article

References (23)

1. Akil H. Scientific strategy in neuroscience: discovery science versus hypothesis -driven research. Neurosci. Q., Summer. 2003;4-5
2. Carrell R.W., Lomas D.A. Conformational disease. Lancet. 350:1997;134-138
3. Ciechanover A., Brundin P. The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg, Neuron. 40:2003;427-446
4. de Vrij F.M.S., Sluijs J.A., Gregori L., Fischer D.F., Hermens W.T.J.M.C., Goldgaber D., Verhaagen J., Van Leeuwen F.W., Hol E.M. Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death. FASEB J. 15:2001;2680-2688
5. +1) in muscle fibers implicates a novel mechanism of molecular misreading in the pathogenesis of inclusion-body myositis. Neurology. 2004;. in press
6. Evans D.A.P., Van der Kley A.A.M., Sonnemans M.A.F., Burbach J.P.H., van Leeuwen F.W. Frameshift mutations at two hot spots in vasopressin transcripts in post-mitotic neurons. Proc. Natl. Acad. Sci. USA. 91:1994;6059-6063
7. Evans D.A.P., Burbach J.P., Swaab D.F., van Leeuwen F.W. Mutant vasopressin precursors in the human hypothalamus: evidence for neuronal somatic mutations in man. Neuroscience. 71:1996;1025-1030
8. Fergusson J., Landon M., Lowe J., Ward L., van Leeuwen F.W., Mayer R.J. Neurofibrillary tangles in progressive supranuclear palsy brains exhibit immunoreactivity to frameshift mutant ubiquitin-B protein. Neurosci. Lett. 279:2000;69-72
9. Fischer D.F., de Vos R.A.I., Proper E.A., van Dijk R., de Vrij F.M.S., Sonnemans M.A.F., Verhage M.C., Sluijs J.A., Hobo B., Zouambia M., Jansen Steur E.N.H., Kamphorst W., Hol E., van Leeuwen F.W. Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain. FASEB J. 17:2003;2014-2024
10. Gray D.A., Tsirigotis M., Woulfe J. Ubiquitin, proteasomes, and the aging brain. Sci. Aging Knowl. Environ. J. 27:2003;1-6
11. Hol E.M., van Dijk R., Sluijs J.A., Gerez L., Hobo B., Tonk M.T., de Haan A., Kamphorst W., Fischer D.F., van Leeuwen F.W. Frameshifted APP (APP+1) is a secretory protein and the level of APP+1 in cerebrospinal fluid is linked to Alzheimer pathology. J. Biol. Chem. 2003;39637-39643
12. Konishi Y., Beach T., Sue L.I., Hampel H., Lindholm K., Shen Y. The temporal localization of frame-shift ubiquitin-B and amyloid precursor protein, and complement proteins in the brain of non-demented control patients with increasing Alzheimer's disease pathology. Neurosci. Lett. 348:2003;46-50
13. Lam A., Pickart C.M., Alban A., Landon M., Jamieson C., Ramage R., Mayer R.J., Layfield R. Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 97:2000;9902-9906
14. Lindsten K., de Vrij F.M.S., Verhoef L.G.G.C., Fischer D.F., van Leeuwen F.W., Hol E.M., Masucci M.G., Dantuma N.P. Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion-degradation substrate that blocks proteasomal degradation. J. Cell Biol. 157:2002;417-429
15. McPhaul L.W., Wang J., Hol E.M., Sonnemans M.A.F., Riley N., Nguyen V., Yuan Q.X., van Leeuwen F.W., French S.W. Molecular misreading of the ubiquitin B gene and hepatic Mallory body formation. Gastroenterology. 122:2002;1878-1885
16. Miller R.J., Wilson S.M. Neurological disease: UPS stops delivering! Trends Pharmacol. Sci. 24:2003;18-23
17. Shoesmith Berke S.J., Paulson H.L. Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration. Curr. Opin. Genet. Dev. 13:2003;253-261
18. Song S., Kim S.-Y., Hong Y.-M., Jo D.-G., Lee J.-Y., Shim S.M., Chung C.-W., Seo S.J., Yoo Y.J., Koh J.-Y., Lee M.-C., Yates A.J., Ichijo H., Jung Y.-K. Essential role of E2-25K/Hip-2 in mediating amyloid-β neurotoxicity. Mol. Cell. 12:2003;553-563
19. van Leeuwen F.W., De Kleijn D.P.V., van den Hurk W.H., Neubauer A., Sonnemans M.A.F., Sluijs J.A., Köycü S., Ramdjielal R.D.J., Salehi A., Martens G.J.M., Grosveld F.G., Burbach J.P.H., Hol E.M. Frameshift mutants of β amyloid precursor protein and ubiquitin-B are prominent in Alzheimer and Down patients. Science. 279:1998;242-247
20. van Leeuwen F.W., Burbach J.P.H., Hol E.M. Mutations in RNA: a first example of molecular misreading in Alzheimer's disease. Trends Neurosci. 21:1998;331-335
21. van Leeuwen F.W., Verwer R.W.H., Spence H., Evans D.A.P., Burbach J.P.H. The magnocellular neurons of the hypothalamo-neurohypophyseal system display remarkable neuropeptidergic phenotypes leading to novel insights in neuronal cell biology. Prog. Brain Res. 119:1998;115-126
22. van Leeuwen F.W., Hol E.M., Hermanussen R.W.H., Sonnemans M.A.F., Moraal E., Fischer D.F., Evans D.A.P., Chooi K.-F., Burbach J.P.H., Murphy D. Molecular misreading in non-neuronal cells. FASEB J. 14:2000;1595-1602
23. van den Hurk W.H., Willems H.J., Bloemen M., Martens G.J. Novel frameshift mutations near short simple repeats. J. Biol. Chem. 276:2001;11496-11498